Android app on Google Play

UBS Downgrades AstraZeneca (AZN) to Neutral

November 4, 2013 8:32 AM EST Send to a Friend
Get Alerts AZN Hot Sheet
Price: $63.49 --0%

Rating Summary:
    6 Buy, 7 Hold, 6 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 24 | Down: 11 | New: 9
Trade AZN Now!
Join SI Premium – FREE
UBS downgraded AstraZeneca (NYSE: AZN) from Buy to Neutral.

For an analyst ratings summary and ratings history on AstraZeneca click here. For more ratings news on AstraZeneca click here.

Shares of AstraZeneca closed at $52.69 yesterday.




You May Also Be Interested In


Related Categories

Downgrades

Related Entities

UBS

Add Your Comment